Publications by authors named "John Ferbas"

Claim this Profile
P
PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways.
David J Sherman, Lei Liu, Edward L LaGory, Preston Fordstrom, Danielle Pruitt, John Ferbas

Cell Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
regulates extrahepatic siRNA-mediated gene silencing efficacy.
Jiamiao Lu, Jasper Lee, Eric Yuan, Devin L Wakefield, Matt Kanke, John Ferbas

Mol Ther Nucleic Acids· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
David J Sherman, Lei Liu, Jennifer L Mamrosh, Jiansong Xie, John Ferbas

Proc Natl Acad Sci U S A· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
David J Sherman, Lei Liu, Jennifer L Mamrosh, Jiansong Xie, John Ferbas

bioRxiv· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of In Vitro Human Skin Models to Assess Potential Immune Activation In Response to Biotherapeutic Attributes and Process-related Impurities.
Joshua M Tokuda, Jiansong Xie, Vibha Jawa, Jenn M Hawkins, John Ferbas

J Pharm Sci· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-clinical similarity of biosimilar ABP 798 with rituximab reference product.
Helen J McBride, Shea Jassem, Vincent Chow, Palanisamy Kanakaraj, Herve Lebrec, John Ferbas

Biologicals· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab.
Shea Jassem, Wei Wang, Heather Sweet, Raffi Manoukian, Vincent Chow, John Ferbas

Pharm Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Precipitation of Antibody Therapeutics After Subcutaneous Injection on Pharmacokinetics and Immunogenicity.
Francis Kinderman, Brittany Yerby, Vibha Jawa, Marisa K Joubert, Nathan H Joh, John Ferbas

J Pharm Sci· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations for the development and validation of flow cytometry-based receptor occupancy assays.
Cherie L Green, Jennifer J Stewart, Carl-Magnus Högerkorp, Alan Lackey, Nicholas Jones, John Ferbas

Cytometry B Clin Cytom· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of receptor occupancy assays by flow cytometry in drug development.
Jennifer J Stewart, Cherie L Green, Nicholas Jones, Meina Liang, Yuanxin Xu, John Ferbas

Cytometry B Clin Cytom· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.
William Stohl, Joan T Merrill, R John Looney, Jill Buyon, Daniel J Wallace, John Ferbas

Arthritis Res Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endotoxin neutralization as a biomonitor for inflammatory bowel disease.
Keith Champion, Laura Chiu, John Ferbas, Michael Pepe

PLoS One· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel assay to measure B cell responses to keyhole limpet haemocyanin vaccination in healthy volunteers and subjects with systemic lupus erythematosus.
John Ferbas, Shelley S Belouski, Michelle Horner, Arunan Kaliyaperumal, Li Chen

Br J Clin Pharmacol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-dimensional second-harmonic generation imaging of fibrillar collagen in biological tissues.
Jiansong Xie, John Ferbas, Gloria Juan

Curr Protoc Cytom· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging image cytometry for the development of clinically feasible biomarkers: evaluation of activated caspase-3 in fine needle aspirate biopsies.
Gloria Juan, Stephen J Zoog, John Ferbas

Methods Cell Biol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A model for harmonizing flow cytometry in clinical trials.
Holden T Maecker, J Philip McCoy, , Michael Amos, John Elliott, John Ferbas

Nat Immunol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample stability and variability of B-cell subsets in blood from healthy subjects and patients with systemic lupus erythematosus.
Shelley Sims Belouski, Daniel Wallace, Michael Weisman, Mariko Ishimori, Lisa Hendricks, John Ferbas

Cytometry B Clin Cytom· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays.
Shelley Sims Belouski, Julie Wilkinson, John Thomas, Keith Kelley, Shen-Wu Wang, John Ferbas

Cytometry B Clin Cytom· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antagonists of CD117 (cKit) signaling inhibit mast cell accumulation in healing skin wounds.
Stephen J Zoog, Andrea Itano, Esther Trueblood, Efrain Pacheco, Lei Zhou, John Ferbas

Cytometry A· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development and validation of a sensitive, dual-flow cell, SPR-based biosensor immunoassay for the detection, semi-quantitation, and characterization of antibodies to darbepoetin alfa and epoetin alfa in human serum.
Daniel T Mytych, Stephon La, Troy Barger, John Ferbas, Steven J Swanson

J Pharm Biomed Anal· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixture modeling approach to flow cytometry data.
Michael J Boedigheimer, John Ferbas

Cytometry A· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of a multiplex flow cytometric bead immunoassay for detection of anti-epoetin alfa antibodies.
John Ferbas, John Thomas, John Hodgson, Amitabh Gaur, Nicole Casadevall

Clin Vaccine Immunol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of HIV-1 infection on lymphocyte phenotypes in blood versus lymph nodes.
Otto O Yang, John J Ferbas, Mary Ann Hausner, Lance E Hultin, Patricia M Hultin

J Acquir Immune Defic Syndr· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of methods to detect and characterize antibodies against recombinant human erythropoietin.
Steven J Swanson, John Ferbas, Patrick Mayeux, Nicole Casadevall

Nephron Clin Pract· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the BIACORE 3000 platform for detection of antibodies against erythropoietic agents in human serum samples.
Stephanie Mason, Stephon La, Daniel Mytych, Steven J Swanson, John Ferbas

Curr Med Res Opin· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis